Company / Working Capital per Share
Revolution Medicines, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.60
FY2025
5-year range
$7.95 / $19.19
FY2021-FY2025
Trend
-26.9%
vs FY2024
Sector context
#52 of 210
Health Care
What the data says
Revolution Medicines, Inc.'s working capital per share of $9.60 is higher than 75% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 7 years, ranging from $7.95 in FY2021 to $123.61 in FY2020.
Based on SEC 10-K filings.
9.60 in FY2025 with a 5-year CAGR of -40.0%. Top quartile in the Health Care sector.
Declined from $19.19 to $9.60 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- -40.0%
- 10-Year CAGR
- -
Sector benchmark
-91.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 26.9% year-over-year.
- Ranks #52 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.60 | -26.9% |
| FY2024 | $13.14 | -31.5% |
| FY2023 | $19.19 | +137.9% |
| FY2022 | $8.07 | +1.5% |
| FY2021 | $7.95 | -93.6% |
| FY2020 | $123.61 | +276.9% |
| FY2019 | $32.80 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026